Company’s operating performance in 2017 and 2016 is shown in the following table: FY2017 FY2016 % Change FY2015 % Change [Amount in Baht Million] Y-o-Y Y-o-Y [2017 VS. 2016] [2016 VS. 2015] Sales Revenue

subsidiary for Quarter 1 of 2019 ending on 31 March 2019 as follows; Statements of Comprehensive Income Revenue from medical treatment The Company generated the revenue from medical treatment for the 1st

detail as follows: I. The operating revenue breakdown by business segment In the second quarter of 2019, the Company and its subsidiaries’ revenue from sales of real estate decreased from the same period

loss compared to the same period of the previous year, which had loss 14.59 million baht. The details as follow: Performance Analysis (1) Revenue Quarter 2-2019 the company and its subsidiaries has total

-Y [2Q18 VS 1Q18] [2Q18 VS 2Q17] FX: THB/USD 31.575 31.529 34.172 Sales Revenue 3,643.3 3,440.2 +5.9% 3,663.5 -0.6% [ Sales Revenue, USD $115.4 $109.1 +5.8% $107.2 +7.6% ] Cost of Sales 2,628.9 2,551.4

business, most of the revenue come from condominium project and commercial building project. Genco and its subsidiary have signed agreements to sell their piece of land and both agreements are due in Q3/2018

) Q1/2020 Q1/2019 Increase/(decrease) % Revene Revenue from sales 99,844 51,495 48,349 93.89 Revenue from services 1,967 25,685 (23,718) (92.34) Cost of Sale (71,275) (41,034) 30,241 (73.70) Cost of

for the three-month period ended 30 June 2020 Compared to the same period last year, the company’s performance increased Baht 24 million as the following reasons: • Total revenue decreased Baht (9

28% 0.36 0.26 0.10 38% Note: The new financial reporting standards were reflected in company’s result of 2020 2 / 5 • Due to COVID 19, revenue increased 3% from rice business and dividend received for

quarter of 2019. Details are as follows: 2nd quarter 6 months Total revenue was THB 846.19 million, a decrease of THB 203.57 million or -19.4%. The main businesses of the Company and its subsidiaries were